EHDEN Webinar – The need for health data in the era of Covid-19

The Covid-19 pandemic underscores the need for high-quality health data that is readily deployed. Europe’s early epidemiological assessments at the start of the pandemic projected infection and mortality rates by orders of magnitude in error. Once the pandemic was in full swing, official statistics in most European countries underreported coronavirus-related deaths. More recently, the retraction of two separate clinical … Read more

OHDSI and EHDEN Partners Obtain Grant Towards Global Research On COVID-19 Treatments

An international cohort of OHDSI collaborators obtained a grant from the COVID-19 Therapeutics Accelerator to lead an effort to compare the effectiveness of treatments, including corticosteroids such as dexamethasone, under current evaluation for COVID-19 across an international observational data network. The Therapeutics Accelerator is an initiative launched by the Bill & Melinda Gates Foundation, Wellcome, … Read more

THE COVID-19 RAPID COLLABORATION CALL CHRONICLE – Part 2

As covered in Part l of the series, the world is still very much fighting the SARS-CoV- 2 pandemic, and in many countries, is still striving to deal with a growing number of COVID-19 patients. Clinicians, scientists, governments and the public all want to know more about characterising patients with COVID-19, how best to manage … Read more

THE COVID-19 RAPID COLLABORATION CALL CHRONICLE – Part 1

The world is still very much fighting the SARS-CoV- 2 pandemic, and in many countries, is still striving to deal with a growing number of COVID-19 patients. Clinicians, scientists, governments and the public all want to know more about characterising patients with COVID-19, how best to manage their care, and if certain treatments are safe … Read more

OHDSI & EHDEN virtual study-a-thon shares real-world evidence to combat COVID-19

With the world fighting the SARS-CoV-2 pandemic and dealing with rapidly growing numbers of COVID-19 patients worldwide,  clinicians, scientists, governments and the public all want to know more about characterising patients with COVID-19, and if certain treatments are safe and effective. To this end, on 26-29 March, the Observational Health Data Sciences and Informatics (OHDSI) … Read more